Fig. 4: Overall survival (OS) curves in subgroups.
From: Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma
Comparisons of the overall survival (OS) between three patients with high total mutational burden (TMB-high; ≥10 mut/Mb) and 11 cases with TMB-low (a) between six patients harboring a TP53 mutation and eight without this mutation (b) or between seven patients harboring a TP53 or RB1 mutation and seven patients without these mutations (c).
